BECLOMETHASONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Beclomethasone, and when can generic versions of Beclomethasone launch?
Beclomethasone is a drug marketed by Amneal Ireland Ltd and is included in one NDA.
The generic ingredient in BECLOMETHASONE is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Beclomethasone
A generic version of BECLOMETHASONE was approved as beclomethasone dipropionate by AMNEAL IRELAND LTD on December 16th, 2025.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BECLOMETHASONE?
- What are the global sales for BECLOMETHASONE?
- What is Average Wholesale Price for BECLOMETHASONE?
Summary for BECLOMETHASONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | BECLOMETHASONE at DailyMed |
US Patents and Regulatory Information for BECLOMETHASONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Ireland Ltd | BECLOMETHASONE DIPROPIONATE | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 213811-001 | Dec 16, 2025 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal Ireland Ltd | BECLOMETHASONE DIPROPIONATE | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 213811-002 | Dec 16, 2025 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
